RESULTS FOR : 'Proteomics'
Showing 1 to 2 of 2 results |    
Keyword Search
Show#
Show#
Results Category/Section
With synthetic biology, drug discovery is going virtual.

Christopher Voigt is a professor of biological engineering at the Massachusetts Institute of Technology, where his lab focuses on synthetic biology. Two major areas of interest for him are developing a genetic programming language for cells and applying synthetic biology to biotechnology challenges.

Restucturing Proteomics: the rise of next-generation affinity reagents.

The ability of antibodies to bind their target proteins with some degree of specificity has elevated them to being among the most useful tools in biology and medicine, with a market value of $60 billion.